Ungan, G., Pons‐Escoda, A., Ulinic, D., Arús, C., Ortega‐Martorell, S., Olier, I., . . . Julià‐Sapé, M. (2024). Early pseudoprogression and progression lesions in glioblastoma patients are both metabolically heterogeneous. NMR in biomedicine, 37(4), e5095-n/a. https://doi.org/10.1002/nbm.5095
Citace podle Chicago (17th ed.)Ungan, Gülnur, Albert Pons‐Escoda, Daniel Ulinic, Carles Arús, Sandra Ortega‐Martorell, Ivan Olier, Alfredo Vellido, Carles Majós, a Margarida Julià‐Sapé. "Early Pseudoprogression and Progression Lesions in Glioblastoma Patients Are Both Metabolically Heterogeneous." NMR in Biomedicine 37, no. 4 (2024): e5095-n/a. https://doi.org/10.1002/nbm.5095.
Citace podle MLA (9th ed.)Ungan, Gülnur, et al. "Early Pseudoprogression and Progression Lesions in Glioblastoma Patients Are Both Metabolically Heterogeneous." NMR in Biomedicine, vol. 37, no. 4, 2024, pp. e5095-n/a, https://doi.org/10.1002/nbm.5095.